General Atlantic Invests in Biotheus

Paul, Weiss advised General Atlantic in its investment in Biotheus, a Chinese clinical-stage biotechnology company which focuses on antibody-based therapeutics, in a financing round. General Atlantic co-led this round of financing with IDG Capital.

The Paul, Weiss team included corporate partners Judie Ng Shortell and Tong Yu; and antitrust counsel Marta Kelly.